NIH clinical trial of investigational vaccine for COVID-19 begins

$ 16.50 · 4.5 (794) · In stock

Study enrolling Seattle-based healthy adult volunteers.

Phase III clinical trial for respiratory syncytial virus (RSV) vaccine begins

Vaccines, Free Full-Text

Genome based Evolutionary study of SARS-CoV-2 towards the Prediction of Epitope Based Chimeric Vaccine

Review of trials currently testing treatment and prevention of COVID-19 - ScienceDirect

Academy of Europe: COVID-19 Bulletin

Management of COVID-19: current status and future prospects - ScienceDirect

COVID-19 mitigation: nanotechnological intervention, perspective, and future scope - Materials Advances (RSC Publishing) DOI:10.1039/D2MA00797E

AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial

An overview of key potential therapeutic strategies for combat in the COVID-19 battle - RSC Advances (RSC Publishing) DOI:10.1039/D0RA05434H

SARS‐CoV‐2: What do we know so far? - Khedkar - 2020 - Acta Physiologica - Wiley Online Library

Investigational COVID-19 vaccine well-tolerated in older adults

Review of trials currently testing treatment and prevention of COVID-19 - ScienceDirect

UM Begins Second COVID-19 Vaccine Clinical Trial

A clinical trial of an investigational COVID-19 vaccine begins